Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) EPS (Basic) (2016 - 2025)

Arcadia Biosciences' EPS (Basic) history spans 12 years, with the latest figure at -$0.98 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 66.89% year-over-year to -$0.98; the TTM value through Dec 2025 reached -$1.71, up 62.5%, while the annual FY2025 figure was -$1.71, 46.06% up from the prior year.
  • EPS (Basic) reached -$0.98 in Q4 2025 per RKDA's latest filing, down from $0.63 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $5.01 in Q4 2023 to a low of -$27.3 in Q4 2021.
  • Average EPS (Basic) over 5 years is -$2.94, with a median of -$1.08 recorded in 2024.
  • Peak YoY movement for EPS (Basic): tumbled 7454.55% in 2022, then skyrocketed 206.74% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$27.3 in 2021, then surged by 106.23% to $1.7 in 2022, then soared by 194.71% to $5.01 in 2023, then plummeted by 159.08% to -$2.96 in 2024, then skyrocketed by 66.89% to -$0.98 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's EPS (Basic) are -$0.98 (Q4 2025), $0.63 (Q3 2025), and -$3.26 (Q2 2025).